Celly Nutrition Teams Up With FUSION Distribution To Expand Quantum BioPharma’s Presence Across Latin American Markets
Celly Nutrition partners with FUSION to launch unbuzzd™ alcohol metabolism aid in the Caribbean region.

.webp&w=1920&q=75&dpl=dpl_6ysJ9LfPjjK65PGFB6RKfCshR8pW)
Quantum BioPharma Ltd. shared an update from Celly Nutrition Corp. announcing the launch of unbuzzd™, a beverage formulated with a blend of vitamins, minerals, and botanical extracts aimed at supporting the body's alcohol metabolism and promoting alertness. Celly Nutrition, led by CEO John Duffy and Co-Chaired by Gerry David, signed a master distribution agreement with FUSION Distribution Group, based in Puerto Rico.
FUSION is a prominent health-conscious food and beverage brand distributor across Puerto Rico, the Caribbean, and Central & South America. Due to this partnership, Celly Nutrition’s alcohol metabolism supplement — unbuzzd™, will be brought to new markets via the powerful distribution network of FUSION.
John Duffy, CEO of Celly Nutrition Corp., stated, "Our partnership with FUSION marks a pivotal moment for unbuzzd™. Their proven success in growing regional brands will help us expand our footprint while delivering a functional, science-backed product. Eduardo Santacana and his team at FUSION are the perfect partners to help us introduce unbuzzd™ to consumers who seek a better way to enjoy alcohol responsibly."
Eduardo Santacana, CEO of FUSION Consulting Group, said "It's an exciting opportunity to be part of unbuzzd's journey. This innovative product helps metabolize alcohol faster, promoting clarity and minimizing the aftereffects of drinking. We're eager to help bring unbuzzd's unique benefits to consumers across the Caribbean and beyond."
The collaboration provides unbuzzd™ access to major retail chains, including Walmart, Walgreens, CVS, Costco, and more, in significant vacation areas where alcohol consumption is typical.

Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.
More from Pharma News
All stories →
Pharming Group Gains FDA Approval for Leniolisib in Children Aged 4–11 with APDS

Lonza Builds Oregon Spray-Drying Facility To Expand SDD Capacity

Discussion